Newsroom

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Dana-Farber Blog

    • Insight Blog screenshot Insight features the latest in cancer care and research news from Dana-Farber.
    • Read the blog 
  • Dana-Farber Facts

    • Dana-Farber 2015 Facts brochureFind statistics on Dana-Farber's patient care, fundraising initiatives and achievements, and phone numbers for patients and families.
    • View Dana-Farber Facts 
  • Dana-Farber View Book

    • Dana-Farber 2011 Viewbook coverThis 24-page magazine gives an overview of Dana-Farber, focusing on its equal investment in research and patient care.
    • View Dana-Farber View Book 
     
  • The Cancer Treatment Revolution

    • The Cancer Treatment Revolution book cover Dr. David Nathan, acclaimed pediatric hematologist and Dana-Farber's president from 1995 – 2000, recounts that history's triumphs and struggles in his book, The Cancer Treatment Revolution.
     

Dana-Farber Spotlight

Sign up to receive Dana-Farber Spotlight, our email newsletter.
View the current issue
Subscribe now
Unsubscribe from mailings 

Media Contacts

Ellen Berlin
Director of Media Relations
617-632-4090
ellen_berlin@dfci.harvard.edu 

Molly McHale
Associate Director of Media Relations
617-632-4090
molly_mchale@dfci.harvard.edu 

 

Top News Releases

Steven Treon, MD, PhD
  • April 08, 2015
  • New Waldenström’s drug shows sustained benefit at two years
  • Dana-Farber researchers report in the New England Journal of Medicine that ibrutinib, a newly approved drug for Waldenström's Macroglobulinemia, continues to control the rare blood cancer, with 95 percent of patients surviving for two years.
Karen Fasciano, PsyD, director of the Young Adult Program at Dana-Farber and Social Worker Phoebe Souza
Rosalind Segal, MD, PhD
  • March 26, 2015
  • Promising drug target identified in medulloblastoma
  • Scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have identified a protein critical to both normal brain development and, in many cases, the development of medulloblastoma, a fast-growing brain tumor that usually strikes children under 10. According to a report in the journal Developmental Cell, halving the level of the protein Eya1 in mice prone to develop medulloblastoma dramatically reduced the animals' risk of dying from the disease.
Anne Gross, PhD, RN

Dana Farber In the News

  • Is fish oil safe during chemotherapy? (reuters.com)
  • Dana-Farber nutritionist Stacy Kennedy, MPH, commented on a recent survey that found many people with cancer were taking fish oil supplements despite research showing they make chemotherapy less effective.

Publications


Content